Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,624 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deep-sea record of impact apparently unrelated to mass extinction in the Late Triassic.
Onoue T, Sato H, Nakamura T, Noguchi T, Hidaka Y, Shirai N, Ebihara M, Osawa T, Hatsukawa Y, Toh Y, Koizumi M, Harada H, Orchard MJ, Nedachi M. Onoue T, et al. Among authors: harada h. Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19134-9. doi: 10.1073/pnas.1209486109. Epub 2012 Nov 5. Proc Natl Acad Sci U S A. 2012. PMID: 23129649 Free PMC article.
Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study.
Tsuboi M, Murakami H, Harada H, Sobue T, Kato T, Atagi S, Tokito T, Mio T, Adachi H, Kozuki T, Sone T, Seike M, Toyooka S, Kitagawa H, Koto R, Yamazaki S, Horinouchi H. Tsuboi M, et al. Among authors: harada h. Thorac Cancer. 2024 May 29. doi: 10.1111/1759-7714.15305. Online ahead of print. Thorac Cancer. 2024. PMID: 38812106 Free article.
Cytokine release syndrome induced by immune checkpoint inhibitor treatment for uterine cervical cancer recurrence: A case report.
Sekimata M, Kinjo Y, Tohyama A, Murakami M, Hashiwaki S, Saito Y, Higami S, Hagimoto M, Taketomi R, Hoshino K, Harada H, Ueda T, Kurita T, Matsuura Y, Yoshino K. Sekimata M, et al. Among authors: harada h. Oncol Lett. 2024 May 17;28(1):331. doi: 10.3892/ol.2024.14463. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38807673 Free PMC article.
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies.
Kaito S, Najima Y, Sadato D, Hirama C, Kishida Y, Nagata A, Konishi T, Yamada Y, Kurosawa S, Yoshifuji K, Shirane S, Shingai N, Toya T, Shimizu H, Haraguchi K, Kobayashi T, Harada H, Okuyama Y, Harada Y, Doki N. Kaito S, et al. Among authors: harada h. Bone Marrow Transplant. 2024 May 23. doi: 10.1038/s41409-024-02311-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38783125
2,624 results